Detalhe da pesquisa
1.
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
Blood
; 143(18): 1873-1877, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457663
2.
Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Int J Mol Sci
; 25(4)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396733
3.
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Haematologica
; 108(9): 2380-2395, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951160
4.
CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 193(1): 171-175, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620089
5.
Co-fuse: a new class discovery analysis tool to identify and prioritize recurrent fusion genes from RNA-sequencing data.
Mol Genet Genomics
; 293(5): 1217-1229, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882166
6.
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission.
Br J Haematol
; 198(3): 600-603, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620965
7.
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
Blood Cancer J
; 13(1): 51, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041128
8.
A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure.
Leukemia
; 36(11): 2678-2689, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038666
9.
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
Blood Adv
; 5(23): 5107-5111, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555849
10.
Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines.
Oncotarget
; 9(78): 34735-34747, 2018 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410673
11.
Editorial: Molecular Mechanisms of Multiple Myeloma.
Front Oncol
; 12: 870123, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35359371